Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Gufic Biosciences Ltd - 509079 - Reg.24(A)-Annual Secretarial Compliance

 Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report30/05/2019 3 Name of the Certifying Firm Gajanan D. Athavale, Company Secretaries 4 Name of the Certifying Individual Gajanan D. Athavale 5Membership TypeFCS 6 Membership Number 9177 7 CP No. 10121 8 Whether any observations/qualification reported by the Secretarial Auditor ? Yes
30-05-2019
Bigul

Gufic Biosciences Ltd - 509079 - Update on board meeting

 The Board Meeting to be held on 29/05/2019 has been revised to 30/05/2019 The Board Meeting to be held on 29/05/2019 has been revised to 30/05/2019
29-05-2019
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Board Meeting Intimation for Approval Of Audited Financial Results Of The Company For The Quarter And Year Ended March 31, 2019

 GUFIC BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2019 ,inter alia, to consider and approve Approval of Audited Financial Results of the Company for the quarter and year ended March 31, 2019
23-05-2019
Bigul

Gufic Biosciences Ltd - 509079 - Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Pursuant to the provisions of Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith certificate received from M/s. Gajanan D. Athavale, Practicing Company Secretary, Mumbai for the half year ended March 31, 2019. Kindly take the same on your record.
26-04-2019
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayGUFIC BIOSCIENCES LTD. 2CININE742B01025 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 11 4Highest Credit Rating during the previous FY BBB- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CARE RATINGS LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: AMI N. SHAH Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER EmailId: mgr_legal@guficbio.com Name of the Chief Financial Officer: D. B. ROONGHTA Designation: CHIEF FINANCIAL OFFICER EmailId: roonghta@guficbio.com Date: 26/04/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
26-04-2019
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 This is to inform you that we are in receipt of the information received from one of the shareholder of the Company by our Registrar & Transfer Agent M/s. Link lntime (India) Private Limited pertaining to stop transfer request as mentioned in the attached letter. Kindly take the same on record.
24-04-2019
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Shareholding for the Period Ended March 31, 2019

 Gufic Biosciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here
17-04-2019
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Compliances-Certificate under Reg. 54 (5) of SEBI (DP) Regulations, 1996

 This is to certify that the securities received for dematerialization during the aforesaid period as required under Regulation 74(5 of the SEBI (Depositories and Participants) Regulations 2018, have been furnished to all the stock exchanges where the shares of the Company are listed. The letter confirming the above as received from our Registrar and Share Transfer Agent, M/s Link Intime India Private Limited is enciosed herewith
15-04-2019
Bigul

Gufic Biosciences Ltd - 509079 - Statement Of Investor Complaints For The Quarter Ended March 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- AMI N. SHAHDesignation :- Company Secretary and Compliance Officer
09-04-2019
Bigul

Gufic Biosciences Ltd - 509079 - Compliance Certificate - Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 As per the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facilities are maintained during the period October 01, 2018 to March 31, 2019 (both days inclusive) by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Private Limited, which is registered as Registrar & Share Transfer Agent in Category-I with the Securities and Exchange Board of India vide Registration Number : INR000004058.
05-04-2019
Next Page
Close

Let's Open Free Demat Account